Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMARCD3 is a potential prognostic marker and therapeutic target in CAFs. | Aging (Albany NY) | 2020 | 33125346 | PubTator, text mining | PubMed |
| Vascular calcification; Stony bridge between kidney and heart. | J Cardiovasc Thorac Res | 2020 | 33123321 | PubTator, text mining | PubMed |
| Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis. | J Neuroinflammation | 2020 | 33121494 | PubTator, text mining | PubMed |
| Integration of gene profile to explore the hub genes of lung adenocarcinoma: A quasi-experimental study. | Medicine (Baltimore) | 2020 | 33120770 | PubTator, text mining | PubMed |
| Magnetic separation of peripheral nerve-resident cells underscores key molecular features of human Schwann cells and fibroblasts: an immunochemical and transcriptomics approach. | Sci Rep | 2020 | 33116158 | PubTator, text mining | PubMed |
| Phosphatidylethanolamine and Phosphatidylserine Synergize To Enhance GAS6/AXL-Mediated Virus Infection and Efferocytosis. | J Virol | 2020 | 33115868 | PubTator, text mining | PubMed |
| Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development. | Int J Mol Sci | 2020 | 33114206 | PubTator, text mining | PubMed |
| Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells. | Cell Syst | 2020 | 33113355 | PubTator, text mining | PubMed |
| Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months. | BMJ Open Diabetes Res Care | 2020 | 33106332 | PubTator, text mining | PubMed |
| The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer. | Cells | 2020 | 33105713 | PubTator, text mining | PubMed |
| Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet? | Cancers (Basel) | 2020 | 33105560 | PubTator, text mining | PubMed |
| AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer. | iScience | 2020 | 33103086 | PubTator, text mining | PubMed |
| Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC. | Front Immunol | 2020 | 33101282 | PubTator, text mining | PubMed |
| Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression. | Int J Mol Sci | 2020 | 33076245 | PubTator, text mining | PubMed |
| Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. | Int Immunopharmacol | 2020 | 33075714 | PubTator, text mining | PubMed |
| Diverse Macrophage Populations Contribute to the Inflammatory Microenvironment in Premalignant Lesions During Localized Invasion. | Front Oncol | 2020 | 33072601 | PubTator, text mining | PubMed |
| Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors. | Front Oncol | 2020 | 33072597 | PubTator, text mining | PubMed |
| Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription. | Ther Adv Chronic Dis | 2020 | 33062239 | PubTator, text mining | PubMed |
| Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors. | Sci Rep | 2020 | 33060620 | PubTator, text mining | PubMed |
| HER2-mediated enhancement of Ebola virus entry. | PLoS Pathog | 2020 | 33052961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=84